CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

COVID-19 UpdateAnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

View More Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

Analytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

News

All News Top News Industry News Bio/Pharma News Supplier News News from Europe Events

All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents

Publications

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Resources

Front & Center Pharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts Marketplace

Enewsletters Magazine North America Magazine Europe

EnewslettersMagazine North AmericaMagazine Europe

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Dosage Forms
Drug Development
Manufacturing
Outsourcing
Quality Systems

TopicSee All >

Analytical Method Development
APIs
Aseptic Processing
Biologic Drugs
Drug Delivery
Equipment
Excipients
Formulation
Packaging
Process Control/PAT
Process Development
QA/QC
Regulatory Action
Supply Chain

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Manufacturing

home

Moving Forward in Serialization

Stakeholders work to meet deadlines, maximize benefits, and close gaps.

Designing Incubators for Cell Therapy Manufacturing

Controlling conditions and preventing contamination are crucial for cell growth.

Crown Bioscience Expands In-Vivo Capacity at UK Facility

December 09, 2021

The additions to Crown Bioscience’s UK facility will increase and expand the company’s current in-vivo offering.

Fujifilm Irvine Scientific Builds Bioprocessing Innovation and Collaboration Center in China

December 03, 2021

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.

60 Million Doses of the COVID-19 Vaccine is Added to Moderna’s Supply Agreement with the UK

December 03, 2021

Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.

FDA Grapples with the Promise and Perils of Gene Therapy

December 03, 2021

High price tags threaten to block patient access to potentially life-saving cures and treatments.

Digitalization Moves Forward in Pharma Equipment and Processes

December 03, 2021

Bio/pharmaceutical manufacturing harnesses the benefits of digital transformation.

Digital Transformation Project Reduces Downtime

December 03, 2021

Polpharma implemented digital technologies, including a digital twin of operations.

Trends in Isolator Equipment

December 03, 2021

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Analytics Advances for Optimizing Downstream Processes

December 03, 2021

Simple, inexpensive real-time analytics are urgently needed for high value products.

Not a Particle of Doubt

December 02, 2021

Particle analysis is a critical component of pharmaceutical development, providing assurances of the quality and performance of the final dosage form.

Accelerating Project Delivery with a Lean Alternative to DBB

December 02, 2021

Lean delivery offers a promising solution to supply and manufacturing bottlenecks by integrating project teams early on and widening the team’s field of view.